Infex Therapeutics Holdings Plc
13917179
Healthy
- Loss before tax (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
31/07/2025
full
Next accounts due
31/01/2027
Confirmation statement
Last: 30/01/2026
Due 13/02/2027
Industry
Officers
director · Since 06/04/2022
DIRECTOR
BRITISH · ENGLAND · Age 65
Also on 1 other board
director · Since 06/04/2022
DIRECTOR
BRITISH · GUERNSEY · Age 75
Also on 3 other boards
director · Since 01/02/2023
PROFESSOR
IRISH · ENGLAND · Age 59
Also on 1 other board
Persons with Significant Control
Mr Jonathan Paul Moulton
British · Guernsey · Age 75
Mereside, Alderley Park, Macclesfield, SK10 4TG
Notified 06/04/2022
Former PSCs
Dr Peter Jackson
Ceased 06/04/2022
Catapult Life Sciences Gp Llp
Ceased 13/06/2023
Charges0 outstanding
MOULTON GOODIES LIMITED (AS SECURITY AGENT)
MOULTON GOODIES LIMITED
CompanyRankvs 9823+ SIC 64209 peers53
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going co
Key FinancialsYear ending 31/07/2025
Net Worth
£523k
Balance sheet strength
Cash
£1.4M
Cash in the bank
Profit Before Tax
-£17.5M
Bottom line earnings
Net Current Assets
£1.7M
Working capital
Current Assets
£3.4M
Current Liabilities
£1.7M
Debtors
£1.9M
Admin Expenses
£6.2M
Operating Profit
-£6.2M
Profit After Tax
-£17.5M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 2.02 | -£2.1M |
| 2024 | 1.30 | -£67k |
| 2023 | 1898.77 | — |
Derived from filed accounts. Not audited figures.